Fairvalue-Calculator Fairvalue-Calculator
EN DE

Surgical Science Sweden AB (SUSRF) Fair Value & Analysis

Healthcare · US · Market cap $280M

Price$4.00
Fair Value$5.19
Upside+29.8%
Quality95/100
Evidence: High Range $2.81 – $7.73

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Surgical Science Sweden AB (SUSRF) currently trades at $4.00, while our model-based Fair Value estimate is $5.19 — implying the stock looks roughly 29.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic trainin…

Open the full interactive analysis →

Similar stocks

Veeva Systems Inc (VEEV) +20% Pro Medicus Limited (PME) -81% BrightSpring Health Services, Inc (BTSG) -61% Tempus AI, Inc (TEM) -74% HealthEquity, Inc (HQY) -6% M3, Inc (MTHRY) +43%

Frequently asked questions

Is Surgical Science Sweden AB (SUSRF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $5.19 versus a price of $4.00 — about +30% (undervalued). Model-based estimate, not financial advice.
What is the fair value of SUSRF?
Our 21-model fair value for Surgical Science Sweden AB is $5.19 (as of Jun 24, 2026), built from audited fundamentals. The current price is $4.00.
What is the quality score of SUSRF?
Surgical Science Sweden AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.